Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_assertion type Assertion NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_head.
- NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_assertion description "[To understand acquired gemcitabine resistance, we generated a gemcitabine-resistant pancreatic cancer cell line using stepwise selection and found that, in addition to the known mechanisms of upregulated expression of ribonucleotide reductase, 14-3-3? expression is dramatically upregulated, and that 14-3-3? overexpression contributes to the acquired resistance to gemcitabine and cross-resistance to cytarabine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_provenance.
- NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_assertion evidence source_evidence_literature NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_provenance.
- NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_assertion SIO_000772 25189999 NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_provenance.
- NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_assertion wasDerivedFrom befree-20150227 NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_provenance.
- NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_assertion wasGeneratedBy ECO_0000203 NP430786.RAZQ8O3cndu0iuing4cEY9Lkl1h7sfKm7LHuxw2dYUSoo130_provenance.